A flexible peptide linker enhances the immunoreactivity of two copies HBsAg preS1 (21-47) fusion protein.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Biotechnology

• Publication date

  2004-01-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JBIOTEC.2003.09.009PMID 14687974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and characterization of the multiplied, recombinant preS1 antigen of hepatitis B virus

  2005cited by this paper
• Development of the diagnostic immunoassay to detect anti-PreS1(21-47aa) antibody--a marker suggesting the health improvement of hepatitis B patients.

  2002cited by this paper
• Antibody responses to preS components after immunization of children with low doses of BioHepB.

  2001cited by this paper
• Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.

  2000cited by this paper
• Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium

  2000cited by this paper
• Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.

  1997cited by this paper
• Hepatitis B vaccination and hepatocellular carcinoma in Taiwan.

  1997cited by this paper
• Global programme for control of hepatitis B infection.

  1995cited by this paper
• Anti—pre‐S responses and viral clearance in chronic hepatitis B virus infection

  1992cited by this paper
• Functions of hepatitis B surface proteins.

  1992cited by this paper
• Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization.

  1990cited by this paper
• Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles.

  1989cited by this paper
• Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.

  1989cited by this paper
• Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

  1988cited by this paper
• Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus infection by ELISA using a pre-S fusion protein expressed in E. coli.

  1988cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• [Hepatitis B virus].

  1987cited by this paper
• Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide.

  1986cited by this paper
• Hepatitis B virus pre‐S gene‐encoded antigenic specificity and anti‐pre‐S antibody: Relationship between anti‐pre‐S response and recovery

  1986cited by this paper
• Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection

  1986cited by this paper
• The hepatitis B virus

  1985cited by this paper
• Cloning and restriction mapping of human HBV genome serotype adr.

  1983cited by this paper
• Cloning and restriction mapping of human HBV genome serotype adr.

  1983cited by this paper

• Designing a Multi-Epitope Vaccine Against MPXV and HIV Based on an Immunoinformatic Approach

  2025cites this paper
• Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate

  2023cites this paper
• Fusion proteins development strategies and their role as cancer therapeutic agents

  2023cites this paper
• Research progress of multi-enzyme complexes based on the design of scaffold protein

  2023cites this paper
• Novel “GaEl Antigenic Patches” Identified by a “Reverse Epitomics” Approach to Design Multipatch Vaccines against NIPAH Infection, a Silent Threat to Global Human Health

  2023cites this paper
• A computational approach to optimising laccase-mediated polyethylene oxidation through carbohydrate-binding module fusion

  2023cites this paper
• Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect

  2021cites this paper
• Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines.

  2021cites this paper
• Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health

  2021cites this paper
• Developing COVID-19 Vaccines by Innovative Bioinformatics Approaches

  2021cites this paper
• Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer.

  2021cites this paper
• Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation

  2020cites this paper
• 3CL hydrolase‐based multiepitope peptide vaccine against SARS‐CoV‐2 using immunoinformatics

  2020cites this paper
• Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approach

  2020cites this paper
• Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide

  2020cites this paper
• Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide

  2020cites this paper
• Assessing the bioactivity of the codon optimized sfGFP-IGF1 fusion protein via interaction with IGFBP3 and induction of cell proliferation

  2019cites this paper
• Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics

  2019cites this paper
• Bioinformatics Predictions, Expression, Purification and Structural Analysis of the PE38KDEL-scfv Immunotoxin Against EPHA2 Receptor

  2019cites this paper
• Separation of the epitopes in a multi-epitope chimera: Helical or flexible linkers?

  2019cites this paper
• Engineering the chloroplast of Chlamydomonas reinhardtii to express the recombinant PfCelTOS-Il2 antigen-adjuvant fusion protein.

  2018cites this paper
• Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

  2018cites this paper
• Effect of a Flexible Linker on Recombinant Expression of Cell-Penetrating Peptide Fusion Proteins and Their Translocation into Fungal Cells

  2016cites this paper
• Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

  2015cites this paper
• Linker length affects expression and bioactivity of the onconase fusion protein in Pichia pastoris.

  2015cites this paper
• Nuclear magnetic resonance spectroscopic studies of the structure and interactions between hepatitis B virus core and surface antigens with peptides

  2014cites this paper
• Fusion protein linkers: property, design and functionality.

  2013cites this paper
• Fusion Protein Linkers: Effects on Production, Bioactivity, and Pharmacokinetics

  2013cites this paper
• A DNA vaccine co-expressing Trichinella spiralis MIF and MCD-1 with murine ubiquitin induces partial protective immunity in mice

  2012cites this paper
• Development of an immunochromatographic strip for rapid detection of antibodies against classical swine fever virus.

  2012cites this paper
• Evaluation of the immune response induced by DNA vaccines expressing MIF and MCD-1 genes of Trichinella spiralis in BALB/c mice

  2011cites this paper
• Heterologous expression and characterization of recombinant glycerol dehydratase from Klebsiella pneumoniae in Escherichia coli

  2007cites this paper
• Expression in and purification of Hepatitis B surface antigen (S-protein) from methylotrophic yeast Pichia pastoris.

  2006cites this paper
• Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.

  2005cites this paper
• Expression of overlapping PreS1 fragment recombinant proteins for the determination of immunogenic domains in HBsAg PreS1 region.

  2004cites this paper